LMO4 and breast cancer: This finding, as well as the deregulation of LMO4 expression in breast cancer and the interaction between LMO4 and the tumour suppressor BRCA1, prompted us to screen non-BRCA1/2 familial breast cancer cases for genetic alterations in LMO4 that may contribute to pathogenesis.